Element Biosciences’ bid to claim a slice of a DNA sequencing technology market dominated by Illumina has been helped by an impressive $277 million financing round backed by a wide range of investors ...

Global genetic sequencing market set to grow to $92 billion by 2033. Decreasing costs in sequencing technology are unlocking new applications. Illumina leads with a significant market share, holding ...